Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Users of Dermal Fillers (US)

Articles with lock require a subscription to GLG News | Request a free trial
August 17, 2007
A Novel Approach to Infection - No More Staph Meetings!
Analysis of: NUCRYST Pharmaceuticals Receives FDA Clearance Of Antimicrobial Barrier Topical Cream | www.medicalnewstoday.com
Author: GLG Expert Contributor
+ Novel antimicrobial barrier will have broad implications for both prophylaxis post-operatively as well as for dermatologic conditions that are suceptible to superinfection (i.e. atopic dermatitis)
August 16, 2007
Lasers for Spider Vein (Phlebectasia) Treatment are Good Enough
Analysis of: Recurrence of Spider Angiomas After Laser Treatment | dermatology.jwatch.org
Author: GLG Expert Contributor
+ Recurrence rates for outdated lasers are a mute point. + The current generation of lasers for vascular lesions are standard of care and deliver as promised.
July 30, 2007
They have improved, but they are not the holy grail
Analysis of: Recurrence of Spider Angiomas After Laser Treatment | dermatology.jwatch.org
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
Lasers are better than they were 10 years ago.  Especially for vascular lesions; however, they are not all purpose machines that can do everything, as evidenced by new ones every year.
July 30, 2007
Let's Get Real HMO's
Analysis of: HMOs to start ad blitz against Medicare cuts | news.yahoo.com
Author: GLG Expert Contributor
Now the shoe is on the other foot.  The HMO's, for the most part, treat the physician with disdain.  They neglect to realize that they are simply a conduit for paying the physician with the patient supplying them with money.  They have decided that they have a G-d-given right to meddle...
July 12, 2007
I would love it
Analysis of: Norwegian hacker says he can bypass AT&T on iPhone | today.reuters.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
It would be great to get an unlocked i-phone...
July 12, 2007
Retinol and Aged Skin
Analysis of: Retinol Benefits Naturally Aged Skin | dermatology.jwatch.org
Author: GLG Expert Contributor
This is a very preliminary report. 
Sunil DhawanJuly 12, 2007
Vaniqa's effect on laser hair removal
Analysis of: Laser Hair Removal Enhanced With Eflornithine Cream | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
I do not believe that Vaniqa will have a negative effect on Laser hair removal as its efficacy is only temporary. In fact we use it as an adjunct for patients with resistant areas. Its use may actually enhance the use of Laser devices as they offer permanence. The products use may be increasing as more...
Sunil DhawanJune 18, 2007
Dermlex Launch
Analysis of: Advitech to finally launch Dermylex in US | www.nutraingredients-usa.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Advitech's launch of Dermylex will not have much of an impact on the psoriasis market. This is due to the fact that the product has minimal studies to back it up, and the company will rely on testimonials. This is not an effective way of marketing to physicians, and is difficult with patients....
Sunil DhawanJune 4, 2007
Melafind Phase three implications
Analysis of: Digital Diagnosis: New Tool for Detecting Skin Cancer | www.ehponline.org
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
If Melafinds phase three study results are positive then physicians will in general be receptive. The only issues are: 1. Ease of use/time to scan 2. Ability for non physician personnel to be trained to use the technology. 3. cost 4. Insurance reimbursement The technology may have more use at larger...
Sunil DhawanJune 4, 2007
Modus product-?efficacy
Analysis of: No Hydroquinone, Means No Worries for Modus. Dr.’s Applaud Europe’s New Import To Fight Signs of Aging | www.rushprnews.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
The new Modus product "without hydroquinone" cannot be fully evaluated on the basis of the currently available information. Decisions based on the opinions of a "Beauty Editor", and 6 years worth of studies with only 4 patients, are tenuous at best, and laughable at worst. It will be difficult to unseat...

Previous Page : 1 2 3 4 5 6 7 8 9 10 Next61 to 70 of 100

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-04T13:45:22.160